Yale New Haven Health names Vincent Tammaro executive vice president and chief financial officer

Monday, April 25, 2016

NEW HAVEN, CT — Vincent Tammaro has been appointed as executive vice president and chief financial officer for Yale New Haven Health System and chief financial officer for Yale New Haven Hospital (YNHH).

“As an outstanding leader in his field and a member of Yale New Haven Health since 2002, we are very excited Vincent will bring his wealth of experience to his new position,” said Marna P. Borgstrom, president and CEO, Yale New Haven Health System and CEO of YNHH. “Vincent is an accomplished executive who understands our system, culture and the unique aspects of Connecticut-based health care financing and delivery.”

Tammaro began at YNHHS in 2002 as director of financial reporting and earned the promotion to senior vice president of corporate finance in 2012. During his YNHHS tenure, Tammaro has integrated financial leadership with operations and played a key role in initiatives such as the Saint Raphael acquisition and integration. In 2014, he completed a GE Health Management Academy fellows program.

A graduate of Pace University’s School of Business, Tammaro began his career at Sound Shore Medical Center in New Rochelle before joining Ernst and Young as a practicing certified public accountant. 


Yale New Haven Hospital (YNHH), part of Yale New Haven Health, is a nationally recognized, 1,541-bed, not-for-profit hospital serving as the primary teaching hospital for the Yale School of Medicine (YSM). Founded as the fourth voluntary hospital in the U.S. in 1826, today, YNHH has two New Haven-based campuses, and also includes Yale New Haven Children's Hospital, Yale New Haven Psychiatric Hospital and Smilow Cancer Hospital. YNHH has received Magnet designation from the American Nurses Credentialing Center, the nation’s highest honor of nursing excellence. YNHH has a combined medical staff of about 4,500 university and community physicians practicing in more than 100 specialties. www.ynhh.org

Similar Articles

08/17/20

Yale New Haven Hospital and Yale School of Medicine partner to test the new COVID-19 vaccine

New Haven, CT (August 17, 2020) – Yale New Haven Hospital and Yale School of Medicine today announced the start of Phase 3 of the Pfizer vaccine trial at the hospital. This groundbreaking study is intended to be one of several vaccine trials to be undertaken in the hopes of finding the most scientifically validated vaccine in the shortest amount of time.

08/11/20

Christopher O’Connor to become president of Yale New Haven Health

New Haven, CT (August 11, 2020) – Working in direct partnership with Health System CEO Marna Borgstrom, Christopher O’Connor will become the new president of Yale New Haven Health (YNHHS) effective October 5, 2020.

07/31/20

Yale New Haven president Richard D’Aquila to step down after nearly 15 years of service with Yale New Haven Health

New Haven, CT (July 31, 2020) – After nearly 15 years of service, Richard D’Aquila has announced his decision to transition out of his role as president of Yale New Haven Hospital and the Health System effective October 5, 2020.